TickrTrends LGND fair value analysis

Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026

manilatimes.net · 2026-07-23

JUPITER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report second quarter 2026 financial results on Thursday, August 6, 2026. The company will hold a conference call beginning at 8:30 a.m. Eastern time to discuss the results and provide a general business update.

Read the full story at manilatimes.net →

Is LGND undervalued? See TickrTrends' fair value analysis →